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Abstract
Background: To address the impact of using multiple sources of data in the United States Medicare Current
Beneficiary Survey (MCBS) compared to using only one source of data to identify those with neuropsychiatric diagnoses.
Methods: Our data source was the 2010 MCBS with associated Medicare claims files (N = 14, 672 beneficiaries). The
MCBS uses a stratified multistage probability sample design to select a nationally representative sample of Medicare
beneficiaries. We excluded those participants in Medicare Health Maintenance Organizations (n = 3894) and
performed a cross-sectional analysis. We classified neuropsychiatric conditions according to four broad categories:
intellectual/developmental disorders, neurological conditions affecting the central nervous system (Neuro-CNS),
dementia, and psychiatric conditions. To account for different baseline prevalence differences of the categories
we calculated the relative increase in prevalence that occurred from adding information from claims in addition
to the absolute increase to allow comparison among categories.
Results: The estimated proportion of the sample with neuropsychiatric disorders increased to 50.0 (both sources)
compared to 38.9 (health survey only) and 33.2 (claims only) with an overlap between sources of only 44.1 %.
Augmenting health survey data with claims led to an increase in estimated percentage of intellectual/developmental
disorders, psychiatric disorders, Neuro-CNS disorders and dementia of 1.3, 5.9, 11.5 and 3.8 respectively. In the
community sample, the largest relative increases were seen for dementia (147.6 %) and Neuro-CNS disorders (87.4 %).
With the exception of dementia, larger relative increases were seen in the facility sample with the greatest being for
intellectual/developmental disorders (121.5 %) and Neuro-CNS disorders (93.8 %).
Conclusions: The magnitude of potentially underestimated sample proportions using health survey only data
varied strikingly according to the category of diagnosis and setting. Augmentation of survey data with claims
appears essential particularly when attempting to estimate proportion of the sample affected by conditions that
cause cognitive impairment which may affect ability to self-report. Augmenting proxy survey data with claims
data also appears to be essential when ascertaining proportion of the facility-dwelling sample affected by
neuropsychiatric disorders.
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Background
The United States Medicare or “Health Insurance for the
Aged and Disabled” program provides coverage for almost
44 million Americans ages 65 and older and 9 million
Americans with a long-term disability [1]. People with
neuropsychiatric impairments comprise a substantial por-
tion of Medicare beneficiaries, but obtaining accurate
prevalence estimates can be challenging. Those with cog-
nitive impairment may under-report conditions associated
with cognitive impairment due to lack of insight, stigma
and other factors. Surveys may only ask about a limited
number of conditions. Similarly, administrative data can
have low sensitivity [2] and may miss cases. Administra-
tive data, however, are commonly used in health services
research because of its availability. Studies involving de-
mentia patients have shown that self-report, administra-
tive data and other sources are complementary; to obtain
accurate prevalence estimates one should use multiple
sources of data [3]. However, dementia is only one of
several health conditions that can account for cognitive
and other neuropsychiatric impairments in the Medicare
population. In particular, beneficiaries with intellectual
disabilities and those with severe mental illness or demen-
tia comprise a substantial portion of the under-65 disabled
Medicare population (37 %) [4]. Since on average they are
much younger (62 and 50 % of those with intellectual dis-
ability and severe mental illness are under age 45), they
tend to be on Medicare longer and can incur substantial
Medicare expenditures [4].
There is increasing recognition of the need to improve
public health surveillance of people with intellectual and
developmental disabilities (ID/DD), with calls for im-
proving data systems and sources from the US Surgeon
General in 2002 and 2005 and the Centers for Disease
Control and Prevention (CDC) in 2009. One approach
to improving public health surveillance is to improve the
use of existing data through novel analytic methods [5].
In addition to ID/DD and dementia, other conditions
such as severe mental illness, stroke and neurological
disorders affecting the brain may lead to cognitive and
other neuropsychiatric impairments. These impairments
are among the most disabling and persistent. They
affect substantial proportions of people who qualify for
Social Security Disability Insurance and subsequently
for Medicare.
The Medicare Current Beneficiary Survey (MCBS) is an
ongoing survey of Medicare beneficiaries which combines
multiple sources of data, including Medicare claims and
survey data collected from a representative sampling of
beneficiaries, to capture the health status, health care use
and expenditures of the Medicare population as a whole.
The Medicare population differs from the general US
population in that it is comprised mainly of people ages
65 and older 84.6 % in 2010) and individuals younger than
age 65 with a long term disability (15.4 %). In general, in
order to be eligible for Medicare, one must be eligible for
either Social Security retirement or disability benefits. A
small fraction (<1 %) of Medicare beneficiaries are eligible
because of having end-stage renal disease requiring dia-
lysis or transplant or amyotrophic lateral sclerosis.
The MCBS provides a valuable opportunity to evaluate
the benefit of using health survey and claims information
to evaluate the prevalence of neuropsychiatric disorders.
Although the MCBS is commonly used for cost estimates
of the entire population, its unique combination of survey
and claims data represents an ideal resource for con-
structing a method that uses multiple sources of data to
identify those with potentially cognitively impairing
neuropsychiatric conditions. Although it does not con-
tain a “gold standard” for measuring these conditions,
it allows examination of the contributions and potential
limitations of each source, and can demonstrate how
estimates of the proportion of the population affected
by these conditions may vary depending on the data
sources used.
The goal of our study was to develop a method that
combines various sources of information available in the
MCBS to identify people with diagnoses of intellectual/
developmental disabilities, dementia, mental illness and
neurological conditions affecting the brain. Since most
studies are done either using claims only or survey only,
we wished to compare the differences in the prevalence
of these disorders using health survey information only,
claims only and health survey plus claims information.
We performed this comparison in the community sample,
long-term care facility sample and overall sample.
Methods
Medicare Current Beneficiary Survey
The United States Medicare Current Beneficiary Survey
(MCBS) uses a stratified multistage probability sample
design to draw a nationally representative sample of
Medicare beneficiaries. The first sampling stage selects
107 nationally representative primary sampling units
(PSUs) which consist of counties (or multiple counties)
with both metropolitan and non-metropolitan areas. The
second stage selects zip code clusters within each PSU.
The third stage, beneficiaries in the selected zip codes
are stratified by seven age groups (under age 45, 45–64,
65–69, 70–74, 75–79, 80–84, and 85 and older) and then
subsampled at rates designed to provide equal probability
samples within each of the seven age groups [6]. Younger
beneficiaries (under age 65) and the oldest beneficiaries
(over age 85) are oversampled to improve estimates for
these vulnerable segments of the population [7, 8]. The
relative sampling rates can range from a low of 1 (70–74)
to a high of almost 4 (under age 45 group) [9]. Every year
a new panel is selected, and each panel remains in the
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survey for four years. Participation is not mandatory
and initial response rates are about 80 % with follow-up
participation rates around 95 %.
We used the 2010 Access to Care sample, which con-
sists of Medicare beneficiaries who were enrolled as of
January 1, 2010 and remained enrolled the entire year. It
includes four panels (n = 14,672), the panels entering in
2007, 2008, 2009 and 2010. Their cumulative response
rates for the 2010 fall survey were 56.6, 58.9, 61.2 and
77.5 % respectively [10]. The MCBS adjusts its survey
weights to account for non-response to reduce potential
non response bias [11]. The MCBS divides respondents
into the community-dwelling and the long-term care
facility sample and tailors the survey so that relevant
questions are asked of each sample. The MCBS defines
long-term care facilities as facilities with at least three
beds which provide “long-term care services throughout
the facility or in a separately identifiable unit” [10].
Long-term care facilities include long-term nursing
homes, assisted living and retirement communities that
provide personal care, psychiatric care facilities, and in-
stitutions for persons with intellectual or developmental
disorders and adult group homes.
The MCBS fall health status and functioning question-
naire has a community version and a long-term care
facility version. The questions and structure of the
community and facility surveys are different although
the topics are similar. The community survey asks
respondents (or their proxy) directly about health diag-
noses, using the language, “Has a doctor ever told you
[or specified person if asking proxy] that (you/he/she)
had [specific diagnosis]?” It also asks which diagnoses
were the primary causes of Medicare eligibility for those
who qualified for Medicare initially because of a disabil-
ity rather than age (primarily beneficiaries under age 65).
Approximately 10 % of community respondents are
interviewed using a proxy. In contrast, no facility re-
spondent is interviewed directly; instead a facility staff
member serves as the proxy. Since nursing homes certi-
fied by the Centers for Medicare and Medicaid Services
are required to perform a clinical assessment of their
patients and fill out a Minimum Data Set (MDS) form
on each patient, the facility staff member is instructed to
refer primarily to a participant’s MDS quarterly review
and if necessary their full MDS assessment for answers
to the MCBS questions. In cases where an MDS assess-
ment is not available, the staff proxy is instructed to
refer to the participant’s medical chart [10].
For participants in a long-term care facility, the MCBS
surveys the facility in which they reside about its charac-
teristics and provides that information in the MCBS
files. The MCBS files also contain information from
Medicare administrative records for all participants.
Medicare claims files of participants are provided with
the 2010 Access to Care MCBS files. We limited our
analysis to Fee-For-Service (FFS) beneficiaries excluding
those who were in an HMO (n = 3894) because Medi-
care HMOs are not required to submit claims. We used
all available claim files: inpatient hospital, outpatient
hospital, skilled nursing facility, physician/supplier,
home health, hospice, and durable medical equipment
claims. The Cost and Use dataset contains a file with
nursing home MDS assessments of participants in the
continuing panels who received an assessment during
the year, but not for the entering panel. Information
from the MDS file and Medicare claims files can be
matched to the Access to Care participants using the
participant identifier.
Neuropsychiatric conditions
The strength of the MCBS is its combination of survey
data, administrative data and claims. We wanted to take
advantage of these various sources of information to do
a broad screen for neurological, cognitive, and psychi-
atric conditions that may cause or are often associated
with cognitive or mental impairment. We classified con-
ditions according to four broad, but clinically distinct
categories: intellectual/developmental disorders (ID/
DD), neurological conditions affecting the central ner-
vous system (Neuro-CNS), dementia and psychiatric
conditions (Table 1). For each of the 4 broad categories
used in building our classification system we developed
an approach that captured and combined information
from two sources: claims and the MCBS health status
and functioning community and facility surveys. Table 1
contains the diagnoses used in each category (column 1),
the International Classification of Diseases – 9 (ICD-9)
codes used to identify the various diagnoses (column 2),
and the health status and functioning survey variables
which were used in the community (column 3) and
facility (column 4) surveys. ICD-9 codes consist of 3–5
numbers. The first three numbers specify a category,
the forth digit specifies the subcategory and the fifth
digit specifies the sub-classification. In Table 1, we use
3 digits when we used all subcategories and sub-
classifications of a particular category, 4 digits when we
used all sub-classifications of a particular subcategory
and 5 digits when we only used a particular sub-
classification.
Intellectual and other developmental disabilities
Claims definition
In addition to ICD-9 codes for intellectual disorder, we
chose developmental disorders (and their related ICD-9)
codes after a review of the literature relying heavily on
the list of conditions associated with intellectual disorder
used in the analysis of the 1994/1995 National Health
Interview Survey Disability Supplements [12, 13]. We
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used ICD-9 codes for the following developmental disor-
ders: intellectual disorder, cerebral palsy, developmental
delay, spina bifida (we excluded spina bifida occulta), de-
formities of brain and skull, chromosomal abnormalities,
muscular dystrophy, congenital infections, congenital
endocrine disorders such as congenital hypothyroidism
and acromegaly, metabolic disorders (Table 1).
Health status and functioning questionnaires
The community health status questionnaire asks “Has a
doctor ever told (you/SP) that (you/he/she) had mental
retardation?” Those under age 65 were asked an add-
itional question, which provided mental retardation as a
possible answer: “Which of these conditions was the
cause of (your/SP’s) becoming eligible for Medicare?” A
Table 1 Medicare Current Beneficiary Survey (MCBS) Variable Names and ICD-9 codes used in classification system
Diagnostic Category
and Sub-Diagnoses
ICD-9 Codes Community Health
Survey (HS) Variables
Facility HS Variables
Intellectual and Developmental Disorders (ID/DD)*
Intellectual Disability 317, 318x, 319, V792 ocmental, emcausc1/emcausc2 = 22** n/a
Cerebral Palsy 343x emcausc1/emcausc2 = 9 cerpalsy
Delay/Pervasive DD 3141, 315xx, 299xx, V93, V98, V99 none none
Spina Bifida 741x none none
Chromosomal 7580-3, 7586-9, 7595, 7598 none none
Brain: Anomalies, Degenerative 330, 740, 742, 7560, 75555 none none
Muscular Dystrophy 3590-2 emcausc1/emcausc2 = 8 none
Congenital Infections 7710-2 none none
Endocrine, Toxic 243, 2530, 7607, 33181 none none
Metabolic 270, 2772, 2775, 27781-2, 27785-9 none none
Psychiatric Disorders
Schizophrenia/Delusion 295, 297, 2980, 2984, 2989 none schizoph
Bipolar 2960-1, 2964-9 none manicdep
Depression/Mood 2962-3, 3004, 311,v790, ocdeprss, emcausc1/ emcausc2 = 34 depress
Personality 301xx none none
Anxiety/Somatic/Dissociative 3000x, 30011-30015, 30021-30023,
3003-3007, 3008x, 3009, 30981
none anxiety
Eating Disorders 3071, 3075x none none
ADHD/Conduct/impulse Control 314xx, 312xx none none
Unspecified n/a ocpsycho, emscausc1/2 = 35 n/a
Neurological (Central Nervous System)
Traumatic Brain Injury 850-4, 8001-4, 8006-9, 8021-4, 8026-9,
8031-4, 8036-9, 8041-4, 8046-9,
95901, 9070, 3102, 2930, 2940
none braininj
Stroke 430, 431, 432x, 433xx, 434xx, 437x, 438xx ocstroke, emcausc1/emcausc2 = 16 stroke
Epilepsy 3450-5, 3457-9 emcausc1/emcausc2 = 5 seizure
Aphasia 7843 none aphasia
Brain: Hydrocephalus, Degenerative 3313-4, 33183, 33189, 3319, 3481 none none
Multiple Sclerosis/Demyelinating 340x, 3411, 3418, 3419 emcausc1/emcausc2 = 7 scleros
Parkinson/Movement 332, 333.0, 333.4 ocparkin, emcausc1/emcausc2 = 27 parknson
Brain Cancer 191, 1920-1, 1983 occbrain none
Dementia
Alzheimer's 3310 no specific alzhmr
Unspecified 290, 2912, 29282, 2941, 2948, 797,
3311, 3312, 33182
ocalzhmr, emcausc1/emcausc2 = 23 dement
*ID/DD Diagnostic Category also used the Minimum Data Set file (ric.mds) variables (ab10a = 0, ab5E = 1); and the facility interview file (ric7) variable "plactype" = 16
**emcausc1 and emcausc2 are the variable names which list the diagnosis (coded as a number) that was the cause of Medicare eligibility for people under 65 at
the time of their initial MCBS interview. Only one of the two had to list the diagnosis to be included
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positive answer to either of these questions was counted
as an intellectual disorder. There were no questions spe-
cifically asking about other developmental disabilities,
but muscular dystrophy and cerebral palsy were among
the listed causes of Medicare eligibility and those who
had these conditions listed were considered to have a
developmental disorder.
The facility health status survey combines ID/DD and
mental illness into one question. “Did (SP)'s record indi-
cate any history of mental retardation, mental illness, or
developmental disability problems? Exclude diagnoses of
organic brain syndrome, Alzheimer's disease, and related
dementia.” Thus it is not possible to separate out those
with an ID/DD purely from the facility health status inter-
view. The survey does contain a specific question on cere-
bral palsy which was included in the survey definition of
ID/DD. Because of this limitation in the MCBS survey,
for this category alone, we supplemented the health sur-
vey information with information from the MDS file and
facility questionnaire. We used the MDS files provided
with the Cost and Use data set, which has a question
(question ab10a) that allows the identification of ID/DD
status. Facilities fill out a survey describing institutional
characteristics including type of facility. Participants in a
facility that responded that it was an “institution for the
mentally retarded/developmentally disabled” were consid-
ered to have an ID/DD. The MDS file provided also con-
tains questions on residential history in the prior 5 years
(question ab5). We considered participants to have ID/
DD if it was indicated in question ab10a or if they had a
history of residential stay in an ID/DD facility.
Psychiatric disorders
Claims definition
Our goal was to include claims that were evidence for a
chronic psychiatric disorder [14], thus we excluded
codes for acute disorders such as acute psychoses, and
adjustment disorders. We also excluded simple phobias.
We did not include codes purely related to alcohol and
substance abuse disorders. The subcategories of psychi-
atric disorders included are listed in Table 1.
Health status and functioning questionnaires
The community health questionnaire asks whether a
doctor has ever told a participant that s/he has depression
or a mental or psychiatric disorder other than depression.
Participants in an entering panel who are under age 65 are
asked whether depression or a mental disorder other than
depression was the cause of Medicare eligibility.
We did not use the facility health status and functioning
survey’s general question asking about mental disorders
combined with mental retardation/developmental disor-
ders. The facility health questionnaire did ask about the
following specific psychiatric disorders: anxiety, bipolar
disorder, depression, and schizophrenia, which were used
in our case definition.
Neurological disorders affecting central nervous system
Claims
For claims we used the ICD-9 codes associated with all
of the disorders asked about in the community and fa-
cility health surveys (Table 1). In addition we added
diagnostic codes for hydrocephalus, encephalopathy
and anoxic brain damage. We coded Parkinson’s disease
using codes for primary (332.1) and secondary (332.2)
Parkinson’s as well as the code for other degenerative
disorders of the basal ganglia (333.0), but not code
333.1 (essential tremor), which has been shown to have
low specificity for Parkinson’s disease [15, 16]. We also
used the code for Huntington’s disease (333.4).
Health status and functioning questionnaires
The community health status and functioning question-
naire surveys participants about the diagnoses of stroke,
Parkinson’s and brain cancer (including metastases). In
addition to stroke and Parkinson’s disease, whether
people were eligible for Medicare because of seizure disor-
ders or multiple sclerosis is also recorded. The facility
questionnaire has staff report on active diagnoses of brain




Prior research has shown that ICD-9 codes are not very
sensitive in distinguishing between Alzheimer’s disease
and non-Alzheimer dementia, but do better when
dementia as a broad category (including both types) is
used [17]. Therefore we combined the diagnostic codes
for Alzheimer’s disease and other dementias/cognitive
impairment into one category [18] (Table 1).
Health status and functioning questionnaires
The community health status questionnaire does not
distinguish between Alzheimer’s disease and other de-
mentias, asking “Has a doctor (ever) told (you/SP) that
(you/he/she) had Alzheimer’s disease or dementia”. In
contrast, the facility questionnaire directs the facility
proxy to mark off active diseases on the MDS assess-
ment and both Alzheimer’s disease and dementia (other
than Alzheimer’s) are listed as options.
Other health conditions
For the sake of comparison and for further evaluation of
the validity of our method, we also included two com-
mon non-neuropsychiatric chronic health conditions
arthritis and diabetes. Diabetes, a condition that can be
asymptomatic, is a condition which we expected to be
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captured well in administrative data given the frequent
use of clinical testing. Arthritis, in contrast, is a condition
often identified because of subjective pain complaints
which may be better captured with survey data. Both are
common in older adults.
We used the National Arthritis Data groups ICD-9
codes for arthritis and other rheumatic conditions which
have been used in other studies to estimate population-
based prevalence [19, 20]. The community survey asks
about rheumatoid arthritis and non-rheumatoid arthritis,
which are also listed in the causes of Medicare eligibility
questions. The facility survey asks about arthritis without
distinction of type.
For diabetes, we used the following claims codes to
identify those with a diabetes-related claim: 250xx, 3620x,
3572, 36641. The community health status and function-
ing questionnaire asks about diabetes and the subtype,
and we did not count those who only reported gestational
or pre-diabetes on the survey as having diabetes. The facil-
ity survey asks about diabetes and diabetic retinopathy
and a positive answer to either of those was considered
evidence of diabetes.
Functional status
Activities of daily living (ADL) limitations were expressed
as five partially hierarchical and mutually exclusive stages
ranging from no difficulty in any ADLs (Stage 0) to diffi-
culty with all ADLs (Stage IV). The initial validation stud-
ies of ADL stages were performed with the Longitudinal
Study of Aging II sample [21–23] and were re-derived in
the MCBS community sample [24]. Community partici-
pants were asked: “Because of a health or physical prob-
lem, (do you/participant if proxy interview) have any
difficulty [by (yourself/himself/herself ) and without special
equipment] with the following: bathing or showering,
dressing, eating, getting in or out of bed or chairs, walk-
ing, and using the toilet.” Those who reported having diffi-
culty or who did not do the activity because of a health
problem were considered to have difficulty.
The phrasing for facility ADL questions was somewhat
different since the facility questions asked about the
degree of assistance required for performing each ADL.
We assigned those in facilities who were reported to be
independent with the ADL without the need of an as-
sistive device as having no difficulty. Those who needed
supervision, any level of assistance or did not do the
activity were considered to have difficulty.
Questions about the instrumental activities of daily liv-
ing (IADLs) are similar in structure to the community
ADL questions in both community and facility question-
naires. We used the questions about managing money
and using the telephone, and assigned difficulty to those
who reported difficulty or who did not perform these
activities because of a health or physical problem.
Demographic variables
Demographic covariates including age, sex, race/ethnicity,
marital status and education and presence of a living child
were obtained primarily from survey data. Where there
was missing data we used other sources. For race/ethni-
city, we used Medicare administrative data. For income
we filled in with income reported in the 2010 Cost and
Use files. We did the same for marital status and presence
of living child, but we also filled in missing data from
household composition, and helper relationship and proxy
relationship data. For example if marital status was miss-
ing, but person lived with a spouse, received help from a
spouse, or the spouse was a proxy, we counted them as
married. Administrative data was also used to determine
whether they lived in a metropolitan area. For dual eligible
status, and participation in an HMO we used variables,
which combined Medicare administrative and survey data.
Facility living status was determined by whether they
received a facility fall 2010 health status and functioning
interview and proxy status for those in the community
was noted.
Analysis
Data analysis was performed with SAS® 9.4 software
(SAS Institute, Inc., Cary, NC, 2013) and we used the
survey procedures to account for the complex survey
design. We used the MCBS Access to Care cross-
sectional weights in all analyses. These weights enable
the production of estimates from the sample that are
generalizable to the Medicare population. They also
enable correction for differential selection probabilities,
non-response, and post stratification adjustments [11, 25].
The 2010 Access to Care cross-sectional weights enable
calculation of weighted estimates which are representative
of the continuously enrolled (from Jan 1 to Dec 31,
2010) Medicare population. All percentages presented
incorporate the survey weights and are thus weighted
percentages.
To assess the effect of adding MCBS survey informa-
tion we calculated sample proportions based on health
survey only, claims data only, and both sources The ID/
DD category also uses information from the facility and
MDS files and these were considered part of “survey”
data for this diagnostic category alone. We used descrip-
tive statistics to compare demographic and functional
characteristics of those identified with a neuropsychiatric
disorder using claims and survey and those without. We
compared the demographic characteristics of the two
groups as part of evaluating construct validity. We ex-
pected that the neuropsychiatric group would have a
higher proportion of people in the youngest and oldest
groups, a higher prevalence of persons reporting low in-
come, ADL and IADL dysfunction, not being married,
being dual eligible, living in a facility and using a proxy.
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Diagnosis proportions were calculated for the commu-
nity, facility and entire (community and facility together)
samples. Differences between the proportion of the sam-
ple identified using health survey data only, and the pro-
portions using health survey plus claims were calculated
in two ways. One was the absolute difference (delta), ob-
tained from subtracting the health survey proportion
from the health survey plus claims proportion:
Delta δð Þ ¼ Health Survey & claims proportion
– health survey only proportion absolute differenceð Þ
The other was the relative percent increase from the
health survey only proportion which was calculated as:
Relative % increase ¼
Health Survey þ Claims proportionð Þ= Survey only proportionð Þ – 1ð Þ
100 %
In addition to the impact on estimated proportion of
the sample with a diagnosis, we also wished to examine
the overlap between cases identified through claims and
those identified through health survey. We expected
there to be cases identified by claims that were not
identified by health surveys because we used major sub-
diagnoses of each category regardless of whether there
was a question about the diagnosis on the community
and facility health surveys. To gain a better understand-
ing of the agreement between sources, we chose individ-
ual sub-diagnoses of the psychiatric (depression) and
Neuro-CNS (stroke, Parkinson’s) categories that had a
specific question about the diagnosis in the facility
health survey, and the community health survey as well
as specific diagnostic codes. We used the total number
of cases identified using claims plus health survey infor-
mation and calculated what percentage were identified
through claims alone, health survey alone and both.
Results
The overall estimated prevalence of neuropsychiatric
disorders using health survey plus claims was 50.0 %.
The distribution of demographic and functional charac-
teristics of those with and without neuropsychiatric dis-
orders followed expected patterns (Table 2). A much
greater percentage of those with neuropsychiatric disor-
ders (10.0 %) lived in a long-term care facility compared
to 0.9 % of those without such a disorder. A greater pro-
portion of those with neuropsychiatric disorders were
under age 65, female, African American, not married,
had low income and dual eligible status compared to
those without neuropsychiatric disorders. As expected
they had a higher prevalence of difficulty with managing
money, using the telephone, and more difficulty with
ADLs. Community-dwelling participants with neuro-
psychiatric disorders had higher rates of proxy usage.
Although the health survey proportion (38.9 %) and
the claims only proportion (33.2 %) were not that different
(because of incomplete overlap), using both sources of
data greatly increased the estimated sample proportion
(50.0 %) which is a 28.6 % relative increase compared to
using health survey alone. The magnitude of the increase
varied by diagnostic category and setting (Table 3). For ex-
ample, the estimated prevalence of ID/DD using health
survey alone was 2.8 % for the entire sample (community
and facility) Adding claims to the health survey informa-
tion resulted in an estimated prevalence of 4.1 %. Because
of the relatively low prevalence of ID/DD disorders in the
population, while the absolute difference in prevalence
was small (1.3 %), the relative increase was 45.2 %. The
largest relative increase was seen with Dementia (91.6 %),
followed by NeuroCNS disorders (88.2 %). Similarly,
among the individual diagnoses, the greatest relative in-
crease (71.3 %) was seen for stroke diagnoses. For depres-
sion, the claims proportion was less than half that of the
health survey proportion and augmenting health survey
data with claims, resulted in the smallest relative increase
(12.4 %). In contrast, for diabetes, the claims proportion
was higher than the survey proportion (27.4 vs. 20.0)
leading to a larger relative increase when augmenting
health survey data with claims.
Strikingly the largest relative increases in diagnosis
proportion were seen for the facility sample. With the
exception of dementia, the relative increases were greater
than those seen in the community sample. Intellectual/
developmental disorders had the largest relative increase
(121.5 %) among the four broad neuropsychiatric disorder
categories and stroke had the largest relative increase
(131.9 %) among the individual neuropsychiatric diagno-
ses. In contrast to its relatively low relative increase in
the community sample (25.2 %), the arthritis proportion
had the largest relative increase (249.6 %) in the facility
sample (Table 3).
Only 44.1 % of potential neuropsychiatric disorder
cases were identified by both claims and health survey
(Fig. 1). The lowest overlap was seen in the ID/DD cat-
egory where only 17.7 % of cases were identified by
both and substantially more cases were identified by
health survey alone (51.2 %) than by claims alone
(31.1 %). The highest overlap was seen in diabetes
where 58.4 % of cases were identified by both, 33.3 %
by claims alone, and only 8.4 % of cases were identified
by health survey alone.
Discussion
Integrating information from various sources in the
MCBS data, most notably health status and functioning
survey data with administrative claims increased the
identification of people with neuropsychiatric disorders.
The estimated proportion of neuropsychiatric disorders
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in the sample using all sources of information varied as
one would expect with demographic and functional
characteristics, providing some evidence for construct
validity. When health survey information was augmented
with claims data the estimated neuropsychiatric disorder
prevalence increased by almost 30 %. Among the four
individual neuropsychiatric categories, the increase was
most notable for respondents with Neuro-CNS disorders
followed by intellectual/developmental disorders.
Surprisingly the increases were greatest for those living
in facilities, where the staff member proxy relied on the
MDS primarily and the medical chart secondarily, raising
the question of the adequacy of MDS assessments. We
expected more concordance with claims which are also
based on the chart. For facilities, the claims proportion
was much closer to the combined proportion than the
health survey proportion was for all categories and dis-
orders except depression.
Table 2 Demographic and Functional Characteristics of those with and without neuropsychiatric disorders (determined using claims
plus MCBS survey data)
Characteristic Overall (n = 10,778) Neuropsych Disorder
(n = 5866 (50 %)
No Neuropsych Disorder
(n = 4912 (50 %))
raw n (column wt. %) column wt. % column wt. %
Age <65 2163 (17.6) 27.3 7.9
65–79 5074 (57.2) 44.4 70.0
80+ 3541 (25.2) 28.3 22.1
Sex Female 5855 (54.3) 57.7 50.8
Male 4923 (45.7) 42.3 49.2
Race/ Ethnicity White NH 8453 (79.3) 78.5 80.0
Black NH 1105 (9.3) 10.0 8.6
Hispanic 711 (6.4) 6.6 6.2
Other 509 (5.0) 4.9 5.2
Marital Status (miss: 5) Married 4791 (49.3) 41.3 57.3
Not Married 5982 (50.7) 58.7 42.7
Income <25K 5971 (50.4) 59.7 41.0
≥25K 4807 (49.6) 40.3 59.0
High School Graduate No 2795 (23.4) 27.0 19.7
Yes 7814 (75.4) 71.1 79.7
Unknown 169 (1.2) 1.9 0.5
In Facility No 9895 (94.6) 90.0 99.1
Yes 883 (5.4) 10.0 0.9
Dual Eligible No 8029 (79.4) 70.7 88.2
Yes 2749 (20.6) 29.3 11.8
Activities of Daily Living Stage (miss: 36) 0 6557 (64.3) 51.0 77.7
I 1727 (15.7) 17.8 13.5
II 960 (8.3) 12.3 4.3
III 985 (8.3) 12.6 4.0
IV 513 (3.4) 6.4 0.5
Difficulty Money (miss: 43) Yes 1901 (13.6) 24.0 3.3
No 8834 (86.4) 76.0 96.7
Difficulty Phone (miss: 42) Yes 1338 (10.2) 15.7 4.6
No 9398 (89.8) 84.3 95.4
Community only
Proxy No 8802 (90.6) 86.7 94.1
Yes 1093 (9.4) 13.3 5.9
Abbreviations: MCBS Medicare Current Beneficiary Survey, wt. weighted, NH non-Hispanic, Neuropsych neuropsychiatric. Source: Authors' analysis using the
Medicare Current Beneficiary Survey, 2010
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In addition, even when the health survey only estimated
proportion and claims only estimated proportion did not
differ greatly from each other, the increases seen when
using both sources suggests each source is capturing
different groups of people. Although some studies use
surveys as the “gold standard” our findings highlight that
this can be inappropriate for neuropsychiatric disorders
which can impair a person’s self-awareness or memory,
thus impairing the ability to report [26]. Using survey in-
formation alone for these diagnoses is likely to lead to un-
derestimates of the proportion of the population affected.
Therefore, particularly for those disorders associated with
Table 3 Estimated Weighted Proportions of Neuropsychiatric Disorders in the Medicare Population by Data Source and the effect of
combining sources








Any Neuropsychiatric Disorder Community Only 36.5 30.5 47.6 11.1 (30.3 %)
Facility Only 79.8 79.4 91.6 11.9 (14.9 %)
Overall 38.9 33.2 50.0 11.1 (28.6 %)
Neuropsychiatric Diagnoses Categories
Intellectual/ Developmental Disorder Community Only 2.6 1.5 3.5 0.9 (34.8 %)
Facility Only 6.2 10.9 13.8 7.6 (121.5 %)
Overall 2.8 2.0 4.1 1.3 (45.2 %)
Psychiatric Disorders Community Only 27.4 16.9 32.8 5.4 (19.9 %)
Facility Only 51.1 48.2 64.4 13.3 (25.9 %)
Overall 28.7 18.7 34.5 5.9 (20.5 %)
NeuroCNS Disorders Community Only 12.2 16.0 22.8 10.7 (87.4 %)
Facility Only 27.5 46.4 53.4 25.8 (93.8 %)
Overall 13.0 17.7 24.5 11.5 (88.2 %)
Dementia Community Only 2.0 4.3 5.0 3 (147.6 %)
Facility Only 40.4 48.0 57.7 17.2 (42.6 %)
Overall 4.1 6.7 7.9 3.8 (91.6 %)
Individual Neuropsychiatric Disorders
Depression Community Only 25.7 10.6 28.6 2.9 (11.2 %)
Facility Only 39.8 33.8 50.2 10.5 (26.3 %)
Overall 26.5 11.8 29.8 3.3 (12.4 %)
Stroke Community Only 10.6 11.0 17.7 7.1 (67.3 %)
Facility Only 12.3 23.5 28.4 16.2 (131.9 %)
Overall 10.7 11.7 18.3 7.6 (71.3 %)
Parkinson's Disease Community Only 1.0 1.0 1.4 0.4 (37.1 %)
Facility Only 5.3 9.0 9.9 4.6 (87.4 %)
Overall 1.2 1.4 1.8 0.6 (48.9 %)
Non-Neuropsychiatric Disorders
Diabetes Community Only 19.7 27.0 29.5 9.8 (49.4 %)
Facility Only 24.9 34.7 37.3 12.4 (49.8 %)
Overall 20.0 27.4 29.9 9.9 (49.4 %)
Arthritis Community Only 56.3 48.4 70.5 14.2 (25.2 %)
Facility Only 19.3 62.7 67.6 48.3 (249.6 %)
Overall 54.3 49.2 70.4 16 (29.5 %)
*For ID/DD and the overall neuropsychiatric categories, the facility "Health Survey" prevalence contains ID/DD cases identified through the MDS (panels 2007, 2008, 2009)
and facility interview files (all panels) in addition to those identified in the facility health status and functioning file
**Delta = difference between all sources prevalence and health survey only prevalence; Relative % is the percent increase in prevalence from adding claims
(delta/health survey prevalence)
Delta may not exactly equal difference of presented numbers because of rounding error
Source: Authors' analysis using the Medicare Current Beneficiary Survey, 2010
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greater cognitive impairments, it appears to be important
to augment survey data with claims data. Claims data may
also be an important source of augmentation when using
interviews done by proxies who may lack full knowledge
of the person’s health history. For those living in facilities
in particular, claims data contributed to a larger relative
increase in diagnosis proportion than the increase seen in
community-dwellers with the exception of dementia. It
may be especially important to augment facility survey
data (based on MDS assessments) with claims data.
On the other hand, claims are notorious for lacking sen-
sitivity for identifying certain disorders [27] and are often
not appropriate as a sole source of identification. A person
with a neuropsychiatric disorder who sees a physician for
other reasons may not have this disorder coded in claims.
In addition, certain providers may not code for psychiatric
disorders if they think they will not be reimbursed for this
code and if the visit also covered other disorders for which
reimbursement is easier. Typically, claims data are more
time-limited than survey data and are not as good as sur-
vey data in ascertaining lifetime occurrence of a disorder.
Our study suggests that the adequacy of either claims
or survey data varies with the type of disorder and setting.
For example, diabetes, an ongoing chronic condition typ-
ically followed using objective laboratory measures and
often requiring frequent encounters (which logically gen-
erate claims), had relatively few cases identified by survey
alone. In contrast, conditions like intellectual disability,
which may not need new medical interventions or assess-
ment (hence few claims), had a large number of cases
identified by survey only. However, more severe forms of
intellectual or developmental disorders may impair ability
to self-report, so these disorders also had a large percent-
age identified by claims alone. Thus, heterogeneity among
individuals with the same or related diagnostic codes—in
their ability to self-report on a survey or in their need for
follow-up visits that generate claims—can lead to substan-
tial differences in the sensitivity of survey versus claims
data for case ascertainment and prevalence estimation. A
similar pattern was seen with stroke. On the one hand,
stroke, which may consist of one episode followed by
recovery, had a higher percentage of cases identified by
Fig. 1 Percent of total cases determined by claims (purple), health survey (orange) and both (magenta) Source: Authors’ analysis of the Medicare
Current Beneficiary Survey, 2010
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survey alone than Parkinson’s disease, which usually is
chronic and requires ongoing health service encounters,
making the latter more easily captured through claims.
However, one effect of stroke can be anosognosia which
would impair ability to report and thus stroke also had a
logically higher percentage of cases identified by claims
alone with a much smaller overlap between the two
sources of data than did Parkinson’s. For arthritis there was
a large dependence on setting where the survey prevalence
was higher in the community, in contrast to the facility set-
ting, where the disorder was better identified by claims.
Limitations
The major limitation of this study is the absence of a “gold
standard” with which to compare our combined measure.
Use of self-report as a gold standard, as has been done in
some studies [28, 29], is not appropriate for conditions that
are commonly associated with impaired cognitive function.
Even medical records cannot be considered the “gold
standard” as it is mainly a comparison of the agreement of
professional coder versus physician/researcher assessment
of the medical records; it does not allow one to assess the
accuracy of the diagnosis in the medical records [30].
Prospective clinician assessments of the individual could
be considered a gold standard but are not practical and
economically feasible to perform on a large scale. Without
a “gold standard,” we are not able to determine our false
positive and negative rates. Our findings, however, are
reasonably consistent across time in the short term as we
obtained consistent results in 2005, 2006 and 2010 data.
In general, claims tend to have much lower sensitivity
than specificity [2, 27]. As such the addition of claims
may not completely compensate for under-reporting on
surveys. While it is difficult to directly compare our esti-
mated sample diagnosis proportions with the prevalence
found in national surveys because of differences in age
structure and disorder definition, our estimates for de-
mentia are reasonably close to the estimates reported by
a study using the 2002 US population-based Health and
Retirement Study Aging, Demographics and Memory
Study (HRS-ADAMS) data [31]. The HRS-ADAMs study
included careful in home assessment, neurocognitive
battery and diagnoses were made by expert multidiscip-
linary consensus panel with and without reference to
the medical records of the participant. For the age
groups 70-79, our estimate of 5.6 % is close to the
HRS-ADAMs estimate for 71–79 year olds of 4.97
(2.61–7.32). Our overall estimate for the 70 and above
age group (11.6 %) is somewhat lower than the HRS-
ADAMs estimate of 13.93 (11.42–16.44) for the age 71
and above group [31], but still reasonably close consider-
ing the different sampling frames, years (2002 vs. 2008)
and methodologies. It does not appear that we have ex-
cessive false positives for dementia.
For depression our community sample estimate of
28.6 % is substantially higher than that of the National
Comorbidity Study-Replication lifetime mood disorder
prevalence of 20.8 % [32]. This difference is driven
somewhat by the very high rate of depression in our
under age 65 sample (58.7 %) which is consistent with
high rates of clinically significant depressive symptoms
(58.3 %) in the under 65 Medicare population reported
in other studies [33]. Our over 65 estimate, however, is
still higher than the equivalent estimates in other studies
and we cannot exclude false positives. The degree to
which false positives or false negatives are a concern can
depend on the application. We chose to be more inclu-
sive as is appropriate for a broad screen, thus it is likely
we included some false positives. Those more concerned
about excluding false positives, however, and willing to
sacrifice sensitivity, can make the criteria more stringent
by requiring multiple occurrences of codes within
claims, as has been done in other studies [29, 34].
In addition, using broader categories as we have done,
can help decrease the number of false negatives (and
false positives.) Other studies have shown that the false
positive rate is higher when trying to identify specific
diagnoses like Alzheimer’s disease [13]. Using a more
general category such as dementia lowers the false positive
rate [13]. Therefore we expect our broader category of
neuropsychiatric disorders to have a lower false positive
rate than narrower categories.
Finally, the study was performed in a US dataset and a
US population-based sample representative of the US
Medicare population. Thus, the specific proportions
presented and the specifics of the survey data are un-
likely to be generalizable to other countries. However
the underlying principles of the approach should be
able to be applied to other surveys/situations where
both types of data are available.
Conclusions
We have created a broad, four-category screen for distinct
neuropsychiatric disorders applicable for population-level
studies, which overcomes some of the limitations in using
claims data or survey data alone to estimate the propor-
tion of the sample that has been affected by neuropsychi-
atric disorders. In addition, we have illustrated that it is
possible to use a national survey such as the MCBS as a
feasible source for surveying adults with developmental
disabilities – an understudied population. We provide a
detailed methodology to enable others to build on our
work as is necessary given updates to ICD codes and
survey variables. We illustrate that relying on either claims
information alone or self-report alone appears to under-
estimate the sample proportion of neuropsychiatric disor-
ders. However the magnitude of under-estimation is
dependent on the specific category of disorder, the specific
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diagnosis, and the setting. Using both sources together is
generally recommended for tasks or projects that require
a more accurate estimate of the proportion of the popu-
lation affected by such conditions. This is especially true
of conditions which may impair an individual’s ability to
self-report (such as dementia), or for which ICD codes
have low sensitivity (such as depression). While our
study focused on the MCBS, it is likely this approach will
also be valuable to augment other surveys querying
about neuropsychiatric conditions.
The MCBS provides an ideal opportunity to understand
the relationship between self- or close proxy-reported dis-
orders and claims-identified disorders and the potential
biases of each source. An understanding of this relation-
ship is invaluable given that it is not financially feasible for
most population-level studies to do a full neuropsychiatric
assessment. Furthermore, because of its innovative ap-
proach to collecting cost data, the MCBS can be used to
better evaluate how using only one source of information
might bias cost estimates for those conditions, which is of
great importance for policy makers. Consequently, both
survey and claims data as combined from the MCBS will
continue to be useful in US population surveillance and
health services research.
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